SDR16C6, which stands for "Short Chain Dehydrogenase/Reductase Family 16C, Member 6," is part of the SDR family of enzymes. It is characterized by its role in oxidoreduction reactions where it catalyzes the NAD(P)(H)-dependent oxidation or reduction of substrates with a relatively short-chain length. SDR16C6, like other members of the SDR family, is involved in a myriad of metabolic processes which can include the metabolism of steroids, fatty acids, and xenobiotics.The SDR enzymes are known for their conserved structural motif, often referred to as the Rossmann fold, which is essential for binding the coenzyme NAD(P)(H). This motif is a key feature that allows these enzymes to participate in the electron transfer required for their catalytic activity. The precise function of SDR16C6, in terms of its specific substrates and biological roles, is not as well characterized as other members of the SDR family.
Nevertheless, the enzymatic activity of SDR16C6 suggests it may play a role in the metabolism of hormones or signaling molecules, contributing to the regulation of various physiological pathways. Changes in the expression or activity of SDR16C6 could feasibly influence metabolic balance, and an understanding of its function might shed light on certain metabolic disorders or contribute to the development of drugs targeting specific metabolic pathways.It's also important to note that SDR enzymes, in general, can be subject to regulation by various cellular factors and might be involved in the cellular response to external stimuli, including drugs and environmental factors. As such, SDR16C6 may also be part of the broader network of enzymes that help maintain cellular homeostasis by modulating metabolic pathways in response to changing cellular needs and conditions.
VEJA TAMBÉM
| Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
Metformin | 657-24-9 | sc-507370 | 10 mg | $77.00 | 2 | |
Um medicamento antidiabético que modula o metabolismo da glucose, influenciando potencialmente as vias relacionadas com o SDR16C6. | ||||||
Insulin Anticorpo () | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $153.00 $1224.00 $12239.00 | 82 | |
Como regulador-chave do metabolismo da glicose e dos lípidos, a insulina poderia afetar indiretamente a atividade da SDR16C6. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Um agonista do PPARγ, influencia o metabolismo dos lípidos e da glicose, com potencial impacto no SDR16C6. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
Outro agonista do PPARγ, altera o metabolismo dos lípidos e da glicose, o que pode afetar o SDR16C6. | ||||||
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $222.00 $593.00 | 1 | |
Um inibidor da alfa-glucosidase, afecta o metabolismo dos hidratos de carbono, influenciando potencialmente o SDR16C6. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
Como agonista do PPARα, o fenofibrato modula o metabolismo lipídico, afectando potencialmente o SDR16C6. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $61.00 $122.00 | 1 | |
Influencia o metabolismo lipídico, com potencial impacto nas vias relacionadas com o SDR16C6. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $252.00 $495.00 | 9 | |
Uma estatina que afecta o metabolismo do colesterol, com potencial impacto no SDR16C6. | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $51.00 | 7 | |
Inibe a lipase, com impacto na digestão e absorção de lípidos, influenciando potencialmente o SDR16C6. | ||||||